Status:
UNKNOWN
Application of Desferal to Treat COVID-19
Lead Sponsor:
Kermanshah University of Medical Sciences
Conditions:
COVID-19
Eligibility:
All Genders
3-99 years
Phase:
PHASE1
PHASE2
Brief Summary
In this study, defined cases of COVID-19 with mild, moderate or severe pneumonia will be treated with standard treatment regimens in combination with IV injection of Deferoxamine. Improvement in clini...
Eligibility Criteria
Inclusion
- Clinical diagnosis of COVID-19 Disease,
Exclusion
- Previous history of allergy to Deferoxamin, Pregnancy, kidney dysfunction,
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04333550
Start Date
April 1 2020
End Date
March 1 2021
Last Update
May 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Kermanshah, Iran, 083